ACSS3 and prostate carcinoma: Acyl-CoA synthetase short chain family member 3 (ACSS3) is a protein that represses prostate cancer progression [96], decreases fatty acid oxidation, enhances anaerobic glycolysis, increases Reactive Oxygen Species production, suppresses mitophagy, and promotes apoptosis [97].